Description
Since 2001, SRSI has been recognized by the Italian Ministry of Health as Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) with the speciality of Molecular Medicine. This speciality recognizes the multidisciplinary research carried out at SRSI, which focuses at both understanding the molecular processes underlying a large number of human diseases and designing new approaches for their treatment.
Thus, the mission of SRSI can be summarized in the following ways:
•promote research aimed at dissecting the molecular pathways responsible for a variety of important human diseases;
•identify new targets and new therapeutic strategies for such diseases;
•create the best environment for young scientists and physicians.
Thanks to the commitment and enthusiasm of scientists, physicians, students and all those working at SRSI, our in-house research has already brought to the clinic new and important therapeutic approaches against life threatening diseases, such as the Wiskott-Aldrich syndrome and the Metachromatic Leukodystrophy. Indeed, recent studies conducted by the San Raffaele-Telethon Institute for gene therapy (TIGET, directed by Prof. Luigi Naldini) have demonstrated how gene therapy with lentiviral vectors represents a new hope for children affected by these genetic disorders.
Organisation's Type
Research Center, Diagnostic Center
